Phase III Trial of Cisplatin Plus Gemcitabine With Either Placebo or Bevacizumab As First-Line Therapy for Nonsquamous Non–Small-Cell Lung Cancer: AVAiL von RECK, Martin, VON PAWEL, Joachim, MANEGOLD, Christian, ZATLOUKAL, Petr, RAMLAU, Rodryg, GORBOUNOVA, Vera, HIRSH, Vera, LEIGHL, Natasha, MEZGER, Jörg, ARCHER, Venice, MOORE, Nicola

Volltext

AVEREL: A Randomized Phase III Trial Evaluating Bevacizumab in Combination With Docetaxel and Trastuzumab As First-Line Therapy for HER2-Positive Locally Recurrent/Metastatic Breas... von GIANNI, Luca, ROMIEU, Gilles H, CHAN, Stephen, WARDLEY, Andrew, GREIL, Richard, MOORE, Nicola, PROT, Sylvie, PALLAUD, Celine, SEMIGLAZOV, Vladimir, LICHINITSER, Michail, SERRANO, Sergio V, MANSUTTI, Mauro, PIVOT, Xavier, MARIANI, Paola, ANDRE, Fabrice, CHAN, Arlene, LIPATOV, Oleg

Volltext

Bevacizumab plus interferon alfa-2a for treatment of metastatic renal cell carcinoma: a randomised, double-blind phase III trial von Escudier, Bernard, Dr, Prof, Pluzanska, Anna, Prof, Koralewski, Piotr, MD, Ravaud, Alain, Prof, Bracarda, Sergio, Prof, Szczylik, Cezary, Prof, Chevreau, Christine, MD, Filipek, Marek, MD, Melichar, Bohuslav, MD, Bajetta, Emilio, Prof, Gorbunova, Vera, Prof, Bay, Jacques-Olivier, MD, Bodrogi, Istvan, MD, Jagiello-Gruszfeld, Agnieszka, MD, Moore, Nicola, MSc

Volltext

R-CHOP with or without bevacizumab in patients with previously untreated diffuse large B-cell lymphoma: final MAIN study outcomes von Seymour, John F, Pfreundschuh, Michael, Trnĕný, Marek, Sehn, Laurie H, Catalano, John, Csinady, Eva, Moore, Nicola, Coiffier, Bertrand

Volltext

Queensland's Disaster Management Officer's Network von Dean, Sarah, Dyer, Matthew, Moore, Nicola

Volltext

Do the malnutrition universal screening tool (MUST) and Birmingham nutrition risk (BNR) score predict mortality in older hospitalised patients? von Henderson, Sarah, Moore, Nicola, Lee, Emma, Witham, Miles D

Volltext

Patients With Proneural Glioblastoma May Derive Overall Survival Benefit From the Addition of Bevacizumab to First-Line Radiotherapy and Temozolomide: Retrospective Analysis of the... von Sandmann, Thomas, Bourgon, Richard, Garcia, Josep, Li, Congfen, Cloughesy, Timothy, Chinot, Olivier L, Wick, Wolfgang, Nishikawa, Ryo, Mason, Warren, Henriksson, Roger, Saran, Frank, Lai, Albert, Moore, Nicola, Kharbanda, Samir, Peale, Franklin, Hegde, Priti, Abrey, Lauren E, Phillips, Heidi S, Bais, Carlos

Volltext

Hypermobility, developmental coordination disorder and physical activity in an Irish paediatric population von Moore, Nicola, Rand, Sarah, Simmonds, Jane

Volltext

71 Sustainably supporting mobility – Developing a walking aid re-use scheme at GOSH von Vamplew, Zoe, Moore, Nicola, Young, Amy, Naunton, Rachel

Volltext

Queensland's disaster management officer's network von Sarah Dean, Matthew Dyer, Nicola Moore

Volltext

Queensland's disaster management officer's network von Sarah Dean, Matthew Dyer, Nicola Moore

Volltext

Queensland's disaster management officer's network von Sarah Dean, Matthew Dyer, Nicola Moore

Volltext

Efficacy and Safety of Bevacizumab-Based Therapy in Elderly Patients with Advanced or Recurrent Nonsquamous Non-small Cell Lung Cancer in the Phase III BO17704 Study (AVAiL) von Leighl, Natasha B., Zatloukal, Petr, Mezger, Jörg, Ramlau, Rodryg, Moore, Nicola, Reck, Martin, Manegold, Christian

Volltext

Increased sporulation underpins adaptation of Clostridium difficile strain 630 to a biologically–relevant faecal environment, with implications for pathogenicity von Ternan, Nigel George, Moore, Nicola Diana, Smyth, Deborah, McDougall, Gordon James, Allwood, James William, Verrall, Susan, Gill, Christopher Ian Richard, Dooley, James Stephen Gerard, McMullan, Geoff

Volltext

Comprehensive reassessment of plasma VEGFA (pVEGFA) as a candidate predictive biomarker for bevacizumab (Bv) in 13 pivotal trials (seven indications) von Bais, Carlos, Rabe, Christina, Wild, Norbert, Swiatek-de Lange, Magdalena, Chen, David, Hong, Kyu, Amler, Lukas, Moore, Nicola, Hegde, Priti S.

Volltext

The Routledge Companion to Popular Music and Humor von Nick Baxter-Moore, Thomas M. Kitts

Volltext

The BERNIE study: A phase II study evaluating addition of bevacizumab (Bv) to chemotherapy in children and adolescents with metastatic rhabdomyosarcoma (mRMS) and non-rhabdomyosarc... von Chisholm, Julia C., Casanova, Michela, Merks, Johannes H., Geoerger, Birgit, Rousseau, Raphael F., Moore, Nicola, Dhalluin, Christophe, Oberlin, Odile

Volltext

Correlation of molecular subtypes with survival in AVAglio (bevacizumab [Bv] and radiotherapy [RT] and temozolomide [T] for newly diagnosed glioblastoma [GB]) von Phillips, Heidi, Sandmann, Thomas, Li, Congfen, Cloughesy, Timothy Francis, Chinot, Olivier L., Wick, Wolfgang, Nishikawa, Ryo, Mason, Warren P., Henriksson, Roger, Saran, Frank, Lai, Albert, Moore, Nicola, Hegde, Priti S., Abrey, Lauren E., Bourgon, Richard, Garcia, Josep, Bais, Carlos

Volltext

BI-22CORRELATION OF MOLECULAR SUBTYPES WITH OVERALL SURVIVAL (OS) IN AVAGLIO, A RANDOMIZED, PLACEBO-CONTROLLED STUDY OF BEVACIZUMAB (BEV) PLUS RADIOTHERAPY (RT) AND TEMOZOLOMIDE (T... von Phillips, Heidi, Sandmann, Thomas, Li, Congfen, Cloughesy, Timothy, Chinot, Olivier L., Wick, Wolfgang, Nishikawa, Ryo, Mason, Warren, Henriksson, Roger, Saran, Frank, Lai, Albert, Moore, Nicola, Hegde, Priti, Abrey, Lauren, Bourgon, Richard, Garcia, Josep, Bais, Carlos

Volltext

Correlation of molecular subtypes with overall survival (OS) in AVAglio, a randomized, placebo-controlled study of bevacizumab (BEV) plus radiotherapy (RT) and temozolomide (TMZ) f... von Phillips, Heidi, Sandmann, Thomas, Li, Congfen, Cloughesy, Timothy, Chinot, Olivier L., Wick, Wolfgang, Nishikawa, Ryo, Mason, Warren, Henriksson, Roger, Saran, Frank, Lai, Albert, Moore, Nicola, Hegde, Priti, Abrey, Lauren, Bourgon, Richard, Garcia, Josep, Bais, Carlos

Volltext